173 related articles for article (PubMed ID: 30250400)
1. Long noncoding RNA ROR promotes breast cancer by regulating the TGF-β pathway.
Hou L; Tu J; Cheng F; Yang H; Yu F; Wang M; Liu J; Fan J; Zhou G
Cancer Cell Int; 2018; 18():142. PubMed ID: 30250400
[TBL] [Abstract][Full Text] [Related]
2. Linc-ROR promotes the progression of breast cancer and decreases the sensitivity to rapamycin through miR-194-3p targeting MECP2.
Zhou Q; Guo J; Huang W; Yu X; Xu C; Long X
Mol Oncol; 2020 Sep; 14(9):2231-2250. PubMed ID: 32335998
[TBL] [Abstract][Full Text] [Related]
3. LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis.
Hou P; Zhao Y; Li Z; Yao R; Ma M; Gao Y; Zhao L; Zhang Y; Huang B; Lu J
Cell Death Dis; 2014 Jun; 5(6):e1287. PubMed ID: 24922071
[TBL] [Abstract][Full Text] [Related]
4. Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer.
Peng WX; Huang JG; Yang L; Gong AH; Mo YY
Mol Cancer; 2017 Oct; 16(1):161. PubMed ID: 29041978
[TBL] [Abstract][Full Text] [Related]
5. Emerging Roles of Long Noncoding RNA Regulator of Reprogramming in Cancer Treatment.
Sun DE; Ye SY
Cancer Manag Res; 2020; 12():6103-6112. PubMed ID: 32765105
[TBL] [Abstract][Full Text] [Related]
6. Linc-ROR Promotes Osteogenic Differentiation of Mesenchymal Stem Cells by Functioning as a Competing Endogenous RNA for miR-138 and miR-145.
Feng L; Shi L; Lu YF; Wang B; Tang T; Fu WM; He W; Li G; Zhang JF
Mol Ther Nucleic Acids; 2018 Jun; 11():345-353. PubMed ID: 29858070
[TBL] [Abstract][Full Text] [Related]
7. LincRNA-ROR promotes invasion, metastasis and tumor growth in pancreatic cancer through activating ZEB1 pathway.
Zhan HX; Wang Y; Li C; Xu JW; Zhou B; Zhu JK; Han HF; Wang L; Wang YS; Hu SY
Cancer Lett; 2016 May; 374(2):261-71. PubMed ID: 26898939
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of LINC-ROR in cancer cell lines and tissues.
Rezaei M; Emadi-Baygi M; Hoffmann MJ; Schulz WA; Nikpour P
Tumour Biol; 2016 Feb; 37(2):1763-9. PubMed ID: 26314857
[TBL] [Abstract][Full Text] [Related]
9. Linc-RoR promotes proliferation, migration, and invasion via the Hippo/YAP pathway in pancreatic cancer cells.
Chen W; Wang H; Liu Y; Xu W; Ling C; Li Y; Liu J; Chen M; Zhang Y; Chen B; Gong A; Xu M
J Cell Biochem; 2020 Jan; 121(1):632-641. PubMed ID: 31452251
[TBL] [Abstract][Full Text] [Related]
10. Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells.
Chen YM; Liu Y; Wei HY; Lv KZ; Fu P
Tumour Biol; 2016 Aug; 37(8):10861-70. PubMed ID: 26883251
[TBL] [Abstract][Full Text] [Related]
11. Role of Long Noncoding RNA Regulator of Reprogramming in Colon Cancer Progression via Epidermal Growth Factor Receptor Signaling.
Chen Y; Yang L; Yin D; Feng X; Jie J; Yao D; Chen J
Technol Cancer Res Treat; 2022; 21():15330338221114707. PubMed ID: 35946134
[No Abstract] [Full Text] [Related]
12. Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer cells.
Fu Z; Li G; Li Z; Wang Y; Zhao Y; Zheng S; Ye H; Luo Y; Zhao X; Wei L; Liu Y; Lin Q; Zhou Q; Chen R
Cell Death Discov; 2017; 3():17004. PubMed ID: 28580169
[TBL] [Abstract][Full Text] [Related]
13. The Long Non-Coding RNA-RoR Promotes the Tumorigenesis of Human Colorectal Cancer by Targeting miR-6833-3p Through SMC4.
Li X; Chen W; Jia J; You Z; Hu C; Zhuang Y; Lin Z; Liu Y; Yang C; Xu R
Onco Targets Ther; 2020; 13():2573-2581. PubMed ID: 32273727
[TBL] [Abstract][Full Text] [Related]
14. Linc-ROR induces epithelial-to-mesenchymal transition in ovarian cancer by increasing Wnt/β-catenin signaling.
Lou Y; Jiang H; Cui Z; Wang L; Wang X; Tian T
Oncotarget; 2017 Sep; 8(41):69983-69994. PubMed ID: 29050257
[TBL] [Abstract][Full Text] [Related]
15. Expression profiling revealed up-regulation of three lncRNAs in breast cancer samples.
Mohebi M; Sattari A; Ghafouri-Fard S; Modarressi MH; Kholghi-Oskooei V; Taheri M
Exp Mol Pathol; 2020 Dec; 117():104544. PubMed ID: 32976818
[TBL] [Abstract][Full Text] [Related]
16. Relevance Function of Linc-ROR in the Pathogenesis of Cancer.
Chen W; Yang J; Fang H; Li L; Sun J
Front Cell Dev Biol; 2020; 8():696. PubMed ID: 32850817
[TBL] [Abstract][Full Text] [Related]
17. Modulation of hypoxia-signaling pathways by extracellular linc-RoR.
Takahashi K; Yan IK; Haga H; Patel T
J Cell Sci; 2014 Apr; 127(Pt 7):1585-94. PubMed ID: 24463816
[TBL] [Abstract][Full Text] [Related]
18. Large intergenic non-coding RNA-ROR as a potential biomarker for the diagnosis and dynamic monitoring of breast cancer.
Zhao T; Wu L; Li X; Dai H; Zhang Z
Cancer Biomark; 2017 Aug; 20(2):165-173. PubMed ID: 28869448
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA ROR is a novel prognosis factor associated with non-small-cell lung cancer progression.
Qu CH; Sun QY; Zhang FM; Jia YM
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4087-4091. PubMed ID: 29028092
[TBL] [Abstract][Full Text] [Related]
20. Functional Relevance of the Long Intergenic Non-Coding RNA Regulator of Reprogramming (Linc-ROR) in Cancer Proliferation, Metastasis, and Drug Resistance.
Peña-Flores JA; Enríquez-Espinoza D; Muela-Campos D; Álvarez-Ramírez A; Sáenz A; Barraza-Gómez AA; Bravo K; Estrada-Macías ME; González-Alvarado K
Noncoding RNA; 2023 Jan; 9(1):. PubMed ID: 36827545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
